Thermo Fisher Scientific to Host Investor Day
WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2024 Investor Day on Thursday,... Read more.
Thermo Fisher Scientific Reports First Quarter 2024 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for... Read more.
Volato Announces Changes to Board Composition
Volato to Announce First Quarter 2024 Results on Wednesday, May 15, 2024 ATLANTA–(BUSINESS WIRE)–Volato Group, Inc. (“Volato,” or the “Company”)... Read more.
Valuedynamx Partnership With Expedia Group Drives 20% Growth
LONDON–(BUSINESS WIRE)–Valuedynamx, a Collinson Company and leading global provider of curated, data-driven purchase rewards, celebrates the first anniversary... Read more.
Revvity Unveils a New Era of Automated Tuberculosis Testing
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time,... Read more.
Summit Bank Group Reports 2024 1st Quarter Earnings
EUGENE, Ore.–(BUSINESS WIRE)–#businessbanking–Summit Bank Group (OTC Pink: SBKO) Q1 2024 Net Income – $2.4 million or $0.31 per fully diluted... Read more.
Vertiv Reports 60% Organic Orders Growth, 8% Net Sales Growth in First Quarter; Updates Full Year 2024 Outlook
First quarter 2024 organic orders up 60% compared to first quarter 2023, book-to-bill ratio 1.5x in first quarter 2024 and record high $6.3 billion backlog at the... Read more.
Tineco Announces the Launch of the Floor One S7 FlashDry, Revolutionizing Cleaning!
PARIS–(BUSINESS WIRE)–Tineco, a specialist in floor care and smart appliances, launches the Tineco Floor One S7 FlashDry, a breakthrough in intelligent... Read more.
Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout
JIANGSU, China–(BUSINESS WIRE)–Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing... Read more.
Astatine Investment Partners Acquires NRG Riverside
GREENWICH, Conn.–(BUSINESS WIRE)–Astatine Investment Partners (“AIP” or “Astatine”, formerly Alinda Capital Partners), a leading private equity... Read more.